Vaxcyte SVP finance, CAO Elvia Cowan sells 19,000 shares for $1,647,060
PCVX•Vaxcyte SVP of Finance and Chief Accounting Officer Elvia Cowan sold 19,000 shares on Oct. 5 at $86.74 each, for $1,647,060. Her holdings fell to 27,860 shares after the sale.
1. Shares sold
Cowan exercised stock options for 19,000 shares on Oct. 5 and sold the same number that day at $86.74 per share. Her holdings fell to 27,860 shares following the sale. She beneficially owned options for 74,068 shares, including the exercised grant priced at $25.92.
